PortfoliosLab logoPortfoliosLab logo
SMRI vs. ROE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

SMRI vs. ROE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bushido Capital US Equity ETF (SMRI) and Astoria US Equal Weight Quality Kings ETF (ROE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SMRI achieves a 18.58% return, which is significantly lower than ROE's 20.98% return.


SMRI

1D
-0.15%
1M
11.41%
YTD
18.58%
6M
18.82%
1Y
35.67%
3Y*
5Y*
10Y*

ROE

1D
-0.04%
1M
8.10%
YTD
20.98%
6M
21.56%
1Y
37.99%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

SMRI vs. ROE - Yearly Performance Comparison


2026 (YTD)202520242023
SMRI
Bushido Capital US Equity ETF
18.58%17.41%19.16%5.11%
ROE
Astoria US Equal Weight Quality Kings ETF
20.98%17.20%18.34%8.12%

Correlation

The correlation between SMRI and ROE is 0.66, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.66

Correlation (All Time)
Calculated using the full available price history since Sep 15, 2023

0.77

The correlation between SMRI and ROE shifts across timeframes, from 0.66 (1 year) to 0.77 (all time), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SMRI vs. ROE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SMRI
SMRI Risk / Return Rank: 8080
Overall Rank
SMRI Sharpe Ratio Rank: 7777
Sharpe Ratio Rank
SMRI Sortino Ratio Rank: 7979
Sortino Ratio Rank
SMRI Omega Ratio Rank: 7474
Omega Ratio Rank
SMRI Calmar Ratio Rank: 8989
Calmar Ratio Rank
SMRI Martin Ratio Rank: 8383
Martin Ratio Rank

ROE
ROE Risk / Return Rank: 8383
Overall Rank
ROE Sharpe Ratio Rank: 8484
Sharpe Ratio Rank
ROE Sortino Ratio Rank: 8282
Sortino Ratio Rank
ROE Omega Ratio Rank: 8080
Omega Ratio Rank
ROE Calmar Ratio Rank: 8383
Calmar Ratio Rank
ROE Martin Ratio Rank: 8989
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SMRI vs. ROE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Bushido Capital US Equity ETF (SMRI) and Astoria US Equal Weight Quality Kings ETF (ROE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SMRIROEDifference
Sharpe ratioReturn per unit of total volatility

-0.28

Sortino ratioReturn per unit of downside risk

-0.16

Omega ratioGain probability vs. loss probability

1.44

1.48

-0.04

Calmar ratioReturn relative to maximum drawdown

5.27

4.41

+0.86

Martin ratioReturn relative to average drawdown

16.62

19.92

-3.30

SMRI vs. ROE - Sharpe Ratio Comparison

The current SMRI Sharpe Ratio is 2.46, which is comparable to the ROE Sharpe Ratio of 2.74. The chart below compares the historical Sharpe Ratios of SMRI and ROE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


SMRIROEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.46

2.74

-0.28

Sharpe Ratio (All Time)

Calculated using the full available price history

1.44

1.39

+0.05

Drawdowns

SMRI vs. ROE - Drawdown Comparison

The maximum SMRI drawdown since its inception was -18.45%, roughly equal to the maximum ROE drawdown of -19.10%. Use the drawdown chart below to compare losses from any high point for SMRI and ROE.


Loading charts...

Drawdown Indicators


SMRIROEDifference

Max Drawdown

Largest peak-to-trough decline

-18.45%

-19.10%

+0.65%

Max Drawdown (1Y)

Largest decline over 1 year

-6.80%

-8.66%

+1.86%

Current Drawdown

Current decline from peak

-1.17%

-0.04%

-1.13%

Average Drawdown

Average peak-to-trough decline

-2.71%

-2.59%

-0.12%

Ulcer Index

Depth and duration of drawdowns from previous peaks

2.15%

1.91%

+0.24%

Volatility

SMRI vs. ROE - Volatility Comparison

Bushido Capital US Equity ETF (SMRI) has a higher volatility of 5.42% compared to Astoria US Equal Weight Quality Kings ETF (ROE) at 3.79%. This indicates that SMRI's price experiences larger fluctuations and is considered to be riskier than ROE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SMRIROEDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.42%

3.79%

+1.63%

Volatility (6M)

Calculated over the trailing 6-month period

10.94%

10.66%

+0.28%

Volatility (1Y)

Calculated over the trailing 1-year period

14.63%

13.94%

+0.69%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

15.84%

15.78%

+0.06%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

15.84%

15.78%

+0.06%

SMRI vs. ROE - Expense Ratio Comparison

SMRI has a 0.71% expense ratio, which is higher than ROE's 0.49% expense ratio.


Dividends

SMRI vs. ROE - Dividend Comparison

SMRI's dividend yield for the trailing twelve months is around 0.95%, more than ROE's 0.94% yield.


PositionTTM202520242023
ROE
Astoria US Equal Weight Quality Kings ETF
0.94%0.97%1.18%0.68%
SMRI
Bushido Capital US Equity ETF
0.95%1.32%0.98%0.45%

Frequently Asked Questions


SMRI and ROE have a correlation of 0.66, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SMRI has higher volatility (5.42%) compared to ROE (3.79%). In terms of maximum drawdown, SMRI dropped -18.45% vs ROE's -19.10%.

On 1-year performance, ROE leads with 37.99% vs 35.67% for SMRI. On fees, ROE is cheaper at 0.49% per year. On volatility, ROE has been the lower-risk option at 3.79%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, ROE has performed better with a 37.99% return vs 35.67%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

ROE is cheaper with a 0.49% expense ratio, compared with 0.71% for SMRI.

SMRI and ROE have nearly identical dividend yields, around 0.95%.

They also come from different issuers: Bushido and Astoria. Their fees differ too: 0.71% for SMRI and 0.49% for ROE.

ROE currently has the higher Sharpe Ratio (2.74 vs 2.46), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SMRI and ROE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer